Skip to main content Skip to navigation Penn Medicine Department of Ophthalmology
Menu

Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Covid Calls

Vaccine Scheduling Update: We’re experiencing very high call volumes from people interested in getting the COVID-19 vaccine. Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.

Menu

Ophthalmology Research

Mouse Retina Cropped
Photo by Kiernan Willett, MD

Research Overview

Penn Ophthalmology is a pioneer in basic and clinical research, leading some of the most advanced ophthalmic research centers and initiatives in the world. The Department is a top recipient of National Eye Institute funding. Nearly all of the department's researchers are also practicing physicians, with specialized clinical knowledge. Last year, Penn Ophthalmology faculty produced 140 publications and had a research impact (H-index) of 117. Members of the Department of Ophthalmology conduct a wide variety of clinical trials. Search for ophthalmology clinical trials here. To learn more about Penn Ophthalmology's most recent advances, check out the news page.

Ophthalmology Labs and Centers

Reversing Blindness with New FDA Approved Retinal Gene Therapy

The gene therapy, called Luxturna, was developed by Jean Bennett, MD, PhD, and Albert M. Maguire, MD.

Talk recorded by CureTalks on June 12, 2018 at 1 pm ET.

Share This Page:
Post Tweet